DSM-Firmenich AG
DSFIR.AS · AMS
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.16 | 0.00 | 0.20 |
| FCF Yield | -0.23% | -0.23% | 1.91% | 1.51% |
| EV / EBITDA | 38.64 | 39.06 | 67.51 | 83.79 |
| Quality | ||||
| ROIC | 1.10% | 1.10% | 0.48% | 0.48% |
| Gross Margin | 36.56% | 36.56% | 31.70% | 31.70% |
| Cash Conversion Ratio | 0.57 | 0.57 | 6.24 | 6.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.82% | -0.32% | -0.14% | 1.40% |
| Free Cash Flow Growth | 0.00% | -111.01% | 0.00% | 592.31% |
| Safety | ||||
| Net Debt / EBITDA | 3.82 | 3.82 | 6.17 | 6.17 |
| Interest Coverage | 10.62 | 10.62 | 8.78 | 8.78 |
| Efficiency | ||||
| Inventory Turnover | 0.63 | 0.63 | 0.67 | 0.67 |
| Cash Conversion Cycle | 122.66 | 122.66 | 116.36 | 113.00 |